Crohn's Disease Treatment Market Size, Share, And Growth Report 2032

Crohn’s Disease Treatment Market: Size

The global Crohn’s Disease Treatment market size was worth around USD 13.99 billion in 2023 and is predicted to grow to around USD 21.06 billion by 2032 with a compound annual growth rate (CAGR) of roughly 4.2% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Crohn’s Disease Treatment market on a global and regional level.

Request Free Sample

Crohn’s Disease Treatment Market: Overview

Crohn disease is an inflammatory bowel disease and can impact the gastrointestinal tract. According to NCBI, Crohn’s Disease is genetically associated with the phenotype. Researchers at NIH have found that NOD2/CARD15 mutations to be related to crohn’s disorder phenotype that can be determined at young age. Moreover, the ailment is usually observed in North America, New Zealand, and Europe. Apparently, the ailment is one of the major chronic relapsing inflammatory bowel disorders that involve inflammation in the digestive system between anus and mouth. Apparently, the infection takes place in colon or ileum or both. Furthermore, NCBI reports that the cases of Crohn’s Disease were found to be falling in the range of nearly two to twenty incidences per one lakh persons since 1980 across the globe.  The disease is impacted by factors such as heredity, immunologic milieu, and environment.

Moreover, the various modes of disease treatment include medicines, nutrient supplements, and surgery. The key aim of treating the disorder is to control inflammation, correct nutritional deficiency, and provide relief to the patients from diarrhea, abdominal pain, and rectal bleeding. Reportedly, the therapy of the ailment is based upon location and seriousness of the crohn’s disorder, its complexities, and medical treatment history for recurring disease symptoms.

Crohn’s Disease Treatment Market: Growth Dynamics

Rise in the gastrointestinal disease and surge in the proportion of patients affected due to Crohn’s Disease will pave a way for the expansion of Crohn’s Disease Treatment Market in the years ahead. Changes in the lifestyles and improper food habits have resulted in occurrence of crohn’s disease, thereby steering the expansion of Crohn’s Disease Treatment market. Escalating demand for biologics for treating Crohn’s disorder and growing awareness about the ailment will push the expansion of Crohn’s Disease Treatment industry over the assessment period. Moreover, massive use of anti-inflammatory medicines along with rapid adoption of biosimilar will play a prominent role in influencing the expansion of Crohn’s Disease Treatment Market over the forecast timespan. Nonetheless, huge treatment costs will curtail the growth of Crohn’s Disease Treatment industry over the forecast timeline. Apart from this, lack of early diagnosis in emerging economies and expiry of copyrights of blockbuster medicines can hinder the expansion of Crohn’s Disease Treatment market.

Furthermore, massive preference for symptomatic medicines and treatment over surgeries, effective disease management for inflammatory bowel disorders, and arrival of new drugs will mark a new chapter in the domain of Crohn’s Disease Treatment and will steer the industry trends.

Request Free Sample

Crohn’s Disease Treatment Market: Report Scope

Crohn’s Disease Treatment Market: Regional Analysis

North American Market To Attain Highest Growth By 2032

The expansion of the Crohn’s Disease Treatment market in North America over 2024-2032 is credited to surge in the number of incidences of disease occurrence witnessed in the region. In addition to this, huge focus of pharma firms on medicine development pertaining to the occurrence of disease in the countries such as the U.S. and Canada will proliferate the expansion of the Crohn’s Disease Treatment industry over the assessment timeline.

Crohn’s Disease Treatment Market: Competitive Players

Key participants profiled in the study are:

• Allergan, Inc.
• Takeda Immune System Suppressors Company Limited
• Bayer AG
• Novartis International AG
• Johnson & Johnson
• AbbVie Inc.
• Boehringer Ingelheim GmbH
• F. Hoffmann-La Roche
• Bristol-Myers Squibb
• GlaxoSmithKline plc
• Eli Lilly and Co.
• Janssen Biotech Inc.
• Pfizer Inc.
• Sanofi

The global Crohn’s Disease Treatment Market is segmented as follows:

By procedures:

• Magnetic Resonance Imaging (MRI)
• Flexible Sigmoidoscopy
• Colonoscopy
• Capsule Endoscopy
• Computerized Tomography (CT)
• Small Bowel Imaging & Double-Balloon Endoscopy
• Others

By drug types:

• Immune System Suppressors
• Anti-Diarrheal
• Antibiotics
• Anti-Inflammatory Drugs Pain Relievers
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa